Lucentis: Clinical Trials

12 trials of Lucentis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 2, 6 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 12
Phase 36Unknown 6
Phase 13Unknown 3

Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD
MW02, Lucentis - Wet Age-related Macular Degeneration
Phase 2 / Phase 3UnknownMabwell (Shanghai) Bioscience Co., Ltd.4332021-05-072022-03-28
Analysis of Aqueous and Vitreous Humor
Ranibizumab, No Ranibizumab - Proliferative Diabetic Retinopathy, Macular Degeneration
Phase 2UnknownCalifornia Retina Consultants452015-07-012017-03-01
25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Ranibizumab, Triamcinolone Acetonide - Proliferative Diabetic Retinopathy
Phase 2 / Phase 3UnknownJUNYAN ZHANG1202015-02-012016-08-25
Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
Ranibizumab, Bevacizumab, Aflibercept - Age Related Macular Degeneration
Phase 2 / Phase 3UnknownEast Florida Eye Institute802014-12-012015-08-11
Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab
Ranibizumab 0.3mg/0.05cc - Diabetic Macular Edema
Phase 1 / Phase 2UnknownSoutheast Retina Center, Georgia302013-04-012014-09-17
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Bevacizumab, Ranibizumab - Retinal Vein Occlusion
Phase 2 / Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2962012-06-012015-07-01
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Ranibizumab, Bevacizumab - Diabetic Macular Edema
Phase 2 / Phase 3UnknownProf. dr. R.O. Schlingemann2462012-06-012015-07-01
Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Ranibizumab, Triamcinolone Acetonide - Wet Macular Degeneration
Phase 2UnknownUniversity Health Network, Toronto302011-01-012011-02-09
Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
Bevacizumab, Ranibizumab - Diabetic Retinopathy, Macular Edema
Phase 2UnknownUniversity of Sao Paulo532010-04-012011-12-13
Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
ranibizumab - Ocular Histoplasmosis Syndrome
Phase 1 / Phase 2UnknownRetina Associates of Kentucky202009-08-012009-08-10
Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)
Intravitreal injection of ranibizumab - Proliferative Diabetic Retinopathy
Phase 1 / Phase 2UnknownUniversity of Sao Paulo222008-09-012009-10-12
Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)
Ranibizumab - Diabetic Macular Edema
Phase 2 / Phase 3UnknownThe Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery402008-05-012011-06-27

Conditions studied

Macular Degeneration (3)  ·  Diabetic Retinopathy (2)  ·  Macular Edema (2)  ·  Glaucoma, Neovascular (1)  ·  Histoplasmosis (1)  ·  Retinal Perforations (1)  ·  Retinal Vein Occlusion (1)  ·  Vision Disorders (1)  ·  Wet Macular Degeneration (1)

Sponsors

University of Sao Paulo (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  California Retina Consultants (1)  ·  East Florida Eye Institute (1)  ·  JUNYAN ZHANG (1)  ·  Mabwell (Shanghai) Bioscience Co., Ltd. (1)  ·  Prof. dr. R.O. Schlingemann (1)  ·  Retina Associates of Kentucky (1)  ·  Southeast Retina Center, Georgia (1)  ·  The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery (1)  ·  University Health Network, Toronto (1)

Countries

United States (4)  ·  China (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Reinier O Schlingemann, MD, PhD (2)  ·  Dennis M Marcus, M.D. (1)  ·  Felipe Almeida, MD (1)  ·  John Kitchens, MD (1)  ·  Robert L Avery, MD (1)  ·  Rodrigo Jorge, MD (1)  ·  Rodrigo Jorge, MD, PhD (1)  ·  Ronald E Frenkel, MD (1)  ·  Ulrike Stolba, MD (1)  ·  Wai-Ching Lam, MD, FRCSC (1)

Results publications

PMID 22457045, PMID 23795985, PMID 27842163